Results 241 to 250 of about 59,572 (271)

Drug Strategies and Treatment-Resistant Schizophrenia

Australian & New Zealand Journal of Psychiatry, 1996
Objectives: The aims of the paper are to review the notion of treatment resis- tance in schizophrenia and consider the factors important in determining non- responsiveness to standard neuroleptic treatment, and to review the strategies currently available in the treatment of such patients, including an evaluation of recently-introduced, novel drug ...
C, Pantelis, T R, Barnes
openaire   +2 more sources

Use of Aripiprazole in treatment resistant schizophrenia

Journal of Psychopharmacology, 2008
For various reasons large numbers of patients treated with Clozapine end up discontinuing the treatment. The authors present the results of switching to Aripiprazole in patients who had to discontinue Clozapine because of neutropenia below the acceptable level for treatment with Clozapine.
D, Hughes, M, Morcos
openaire   +2 more sources

Clozapine for Treatment-Resistant Schizophrenia

American Journal of Therapeutics, 2016
Peter, Manu, Eugene, Grudnikoff
openaire   +2 more sources

[Treatment-resistant schizophrenia].

Revue medicale de Bruxelles, 2014
Schizophrenia is a psychiatric disorder that causes severe cognitive, behavioral and social dysfunction, responsible for a shortening of the life expectancy of patients, with an increased risk of suicide, cardiovascular disease and cancer. The management of patient with schizophrenia is global and atypical antipsychotics, antagonizing dopamine pathway,
openaire   +1 more source

[Management of treatment resistance-Treatment-resistant schizophrenia].

Der Nervenarzt
Despite a very high prevalence and substantial impairments among affected individuals, treatment-resistant schizophrenia (TRS) has not been sufficiently researched in clinical research in the field of psychiatric disorders and the pathophysiology is still poorly understood.
Elias, Wagner, Stefan, Borgwardt, Alkomiet, Hasan   +2 more
openaire   +1 more source

Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia

Journal of Affective Disorders, 2021
Chuanjun Zhuo, Yong Xu, Haibo Wang
exaly  

Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation

Psychiatry Research, 2022
Naista Zhand, Philip D Harvey
exaly  

Treatment resistant schizophrenia

2010
Marc Turiault, Caroline Cohen, Guy Griebel, David E. Nichols, Britta Hahn, Gary Remington, Ronald F. Mucha, Emma Childs, Darren R. Christensen, Warren K. Bickel, Darren R. Christensen, Warren K. Bickel, Andrea Bari, Rosa M. M. de Almeida, Klaus A. Miczek, Sheldon Preskorn, Megan M. Dahmen, Janka Lincoln, Emma Childs, Tomasz Schneider, Pierre Baumann, Britta Hahn, W. Wolfgang Fleischhacker, W. Wolfgang Fleischhacker, W. Wolfgang Fleischhacker, Trevor W. Robbins, Emma Childs, Lawrence Scahill, Lawrence Scahill, Lawrence Scahill, Lawrence Scahill, Ben J. Harrison, Christos Pantelis, Warren H. Meck, Catalin V. Buhusi, Catalin V. Buhusi, Warren H. Meck, Warren H. Meck, Catalin V. Buhusi, Seiya Miyamoto, Harriet de Wit, David C. S. Roberts, Robert L. Balster, Robert Kessler, Ronald L. Cowan, Johannes Mosbacher, Emma Childs, Sara Tomlinson, Glen B. Baker, Sara Tomlinson, Glen B. Baker, Mark Slifstein, Suzanne H. Mitchell, Harriet de Wit, Tara L. White, Richard A. Depue, Martine Cador, Lawrence H. Price, Jean-Michel Scherrmann, Etienne Sibille, Nicole Edgar, Christof Baltes, Thomas Mueggler, Markus Rudin, Thomas Steckler, Josee E. Leysen, Stephen M. Stahl, Meghan M. Grady, Klaus A. Miczek, Joseph Zohar, Klaus A. Miczek, Linda Lundström, Silvia Gatti McArthur, Will Spooren, Gary Remington, Ashwini Padhi, Naomi A. Fineberg, Josee E. Leysen, Emma Childs, Robert L. Balster, Subhash C. Pandey, Michael H. Bloch, Sidney H. Kennedy, Sakina J. Rizvi, Clemens Kirschbaum, W. Wolfgang Fleischhacker, Harriet de Wit, Theodora Duka, David S. Middlemas, David B. Bylund, A. Claudio Cuello, David E. Nichols, Lawrence H. Price, Simon N. Young, Peter Verhaert, Per Svenningsson, Per E. Andrén, Tiffany Thomas, Robert L. Findling   +98 more
openaire   +2 more sources

Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study

Biological Psychiatry, 2019
Yusuke Iwata, Eric Plitman, Fernando Caravaggio   +2 more
exaly  

Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia

Current Pharmaceutical Design, 2020
Yi-Hang Chiu, Chia-Yueh Hsu, Mong-Liang Lu   +2 more
exaly